Nancy A. Johnson

Array ( [id] => 3795221 [patent_doc_number] => 05780596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Binding proteins to malignant cell type markers of the interior nuclear matrix' [patent_app_type] => 1 [patent_app_number] => 8/467781 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 12757 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780596.pdf [firstpage_image] =>[orig_patent_app_number] => 467781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868803 [patent_doc_number] => 05824286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Mammography method' [patent_app_type] => 1 [patent_app_number] => 8/464048 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1744 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824286.pdf [firstpage_image] =>[orig_patent_app_number] => 464048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3951861 [patent_doc_number] => 05955583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Antibodies to cGMP-binding, cGMP-specific phospodiesterase' [patent_app_type] => 1 [patent_app_number] => 8/463949 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 22644 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955583.pdf [firstpage_image] =>[orig_patent_app_number] => 463949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857567 [patent_doc_number] => 05792616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Antibodies to human cripto protein' [patent_app_type] => 1 [patent_app_number] => 8/463616 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 2999 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792616.pdf [firstpage_image] =>[orig_patent_app_number] => 463616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4023920 [patent_doc_number] => 05993828 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Tumor associated antigen compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/462570 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 17364 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/993/05993828.pdf [firstpage_image] =>[orig_patent_app_number] => 462570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3883513 [patent_doc_number] => 05833983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Interleukin 2 receptor and applications thereof' [patent_app_type] => 1 [patent_app_number] => 8/463491 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2801 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/833/05833983.pdf [firstpage_image] =>[orig_patent_app_number] => 463491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769310 [patent_doc_number] => 05756342 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'BCRF1 antagonists for treating epstein-barr virus infections' [patent_app_type] => 1 [patent_app_number] => 8/461778 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4327 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756342.pdf [firstpage_image] =>[orig_patent_app_number] => 461778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682760 [patent_doc_number] => 05695755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Peripheralization of hematopoietic stem cells' [patent_app_type] => 1 [patent_app_number] => 8/463128 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 9588 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695755.pdf [firstpage_image] =>[orig_patent_app_number] => 463128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869046 [patent_doc_number] => 05824304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Peripheralization of hematopoietic stem cells' [patent_app_type] => 1 [patent_app_number] => 8/463298 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 9587 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824304.pdf [firstpage_image] =>[orig_patent_app_number] => 463298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4055799 [patent_doc_number] => 05863745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Recombinant antibody-toxin fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/461825 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5314 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863745.pdf [firstpage_image] =>[orig_patent_app_number] => 461825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767490 [patent_doc_number] => 05773292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood' [patent_app_type] => 1 [patent_app_number] => 8/463500 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 12522 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773292.pdf [firstpage_image] =>[orig_patent_app_number] => 463500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057658 [patent_doc_number] => 05866127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Vascular permeability factor targeted compounds' [patent_app_type] => 1 [patent_app_number] => 8/464956 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 12 [patent_no_of_words] => 5767 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866127.pdf [firstpage_image] =>[orig_patent_app_number] => 464956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941015 [patent_doc_number] => 05872217 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Antibodies which specifically bind a cancer related antigen' [patent_app_type] => 1 [patent_app_number] => 8/469007 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 44 [patent_no_of_words] => 21137 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872217.pdf [firstpage_image] =>[orig_patent_app_number] => 469007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690008 [patent_doc_number] => 05696237 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Recombinant antibody-toxin fusion protein' [patent_app_type] => 1 [patent_app_number] => 8/463163 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6047 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696237.pdf [firstpage_image] =>[orig_patent_app_number] => 463163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756415 [patent_doc_number] => 05721107 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Antibodies to G protein coupled glutamate receptors' [patent_app_type] => 1 [patent_app_number] => 8/463642 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 18715 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721107.pdf [firstpage_image] =>[orig_patent_app_number] => 463642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799891 [patent_doc_number] => 05830471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Methods and compositions comprising anti-lam-1 antibodies' [patent_app_type] => 1 [patent_app_number] => 8/459097 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 2179 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830471.pdf [firstpage_image] =>[orig_patent_app_number] => 459097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1479480 [patent_doc_number] => 06451981 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Antibodies against lymphocyte-associated cell surface protein LAM-1' [patent_app_type] => B1 [patent_app_number] => 08/458808 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 2259 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451981.pdf [firstpage_image] =>[orig_patent_app_number] => 08458808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3626422 [patent_doc_number] => 05686292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Hepatocyte growth factor receptor antagonist antibodies and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/460368 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10943 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686292.pdf [firstpage_image] =>[orig_patent_app_number] => 460368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699792 [patent_doc_number] => 05646036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Nucleic acids encoding hepatocyte growth factor receptor antagonist antibodies' [patent_app_type] => 1 [patent_app_number] => 8/459388 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 10937 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646036.pdf [firstpage_image] =>[orig_patent_app_number] => 459388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3941035 [patent_doc_number] => 05872218 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Human platelet-derived growth factor receptor extracellular domain antibodies' [patent_app_type] => 1 [patent_app_number] => 8/460510 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 21336 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872218.pdf [firstpage_image] =>[orig_patent_app_number] => 460510 [rel_patent_id] =>[rel_patent_doc_number] =>)